Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study

被引:521
作者
Booth, Gillian L. [1 ]
Kapral, Moira K.
Fung, Kinwah
Tu, Jack V.
机构
[1] St Michaels Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON M5C 2T2, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[4] Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, Toronto, ON, Canada
[5] Univ Hlth Network Womens Hlth Program, Toronto, ON, Canada
[6] Inst Clin Evaluat Sci, Toronto, ON, Canada
关键词
D O I
10.1016/S0140-6736(06)68967-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Adults with diabetes are thought to have a high risk of cardiovascular disease (CVD), irrespective of their age. The main aim of this study was to find out the age at which people with diabetes develop a high risk of CVD, as defined by: an event rate equivalent to a 10-year risk of 20% or more; or an event rate equivalent to that associated with previous myocardial infarction. Methods We did a population-based retrospective cohort study using provincial health claims to identify all adults with (n=379 003) and (n=9 018 082) without diabetes mellitus living in Ontario, Canada, on April 1, 1994. Individuals were followed up to record CVD events until March 31, 2000. Findings The transition to a high-risk category occurred at a younger age for men and women with diabetes than for those without diabetes (mean difference 14.6 years). For the outcome of acute myocardial infarction (AMI), stroke, or death from any cause, diabetic men and women entered the high-risk category at ages 47.9 and 54.3 years respectively. When we used a broader definition of CVD that also included coronary or carotid revascularisation, the ages were 41.3 and 47.7 years for men and women with diabetes respectively. Interpretation Diabetes confers an equivalent risk to ageing 15 years. However, in general, younger people with diabetes (age 40 or younger) do not seem to be at high risk of CVD. Age should be taken into account in targeting of risk reduction in people with diabetes.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 40 条
  • [1] [Anonymous], 2005, DIABETES CARE, V28, pS4
  • [2] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [3] Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease - 10-year follow-up of the Hoorn Study
    Becker, A
    Bos, G
    de Vegt, F
    Kostense, PJ
    Dekker, JM
    Nijpels, G
    Heine, RJ
    Bouter, LM
    Stehouwer, CDA
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (15) : 1406 - 1413
  • [4] BOOTH GL, 2003, DIABETES ONTARIO ICE, P95
  • [5] The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men
    Cho, E
    Rimm, EB
    Stampfer, MJ
    Willett, WC
    Hu, FB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) : 954 - 960
  • [6] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [7] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
    Colhoun, HM
    Betteridge, DJ
    Durrington, PN
    Hitman, GA
    Neil, HAW
    Livingstone, SJ
    Thomason, MJ
    Mackness, MI
    Charlton-Menys, V
    Fuller, JH
    [J]. LANCET, 2004, 364 (9435) : 685 - 696
  • [8] European guidelines on cardiovascular disease prevention in clinical practice -: Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice
    De Backer, G
    Ambrosioni, E
    Borch-Johnsen, K
    Brotons, C
    Cifkova, R
    Dallongeville, J
    Ebrahim, S
    Faergeman, O
    Graham, I
    Mancia, G
    Cats, VM
    Orth-Gomér, K
    Perk, J
    Pyörälä, K
    Rodicio, JL
    Sans, S
    Sansoy, V
    Sechtem, U
    Silber, S
    Thomsen, T
    Wood, D
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2003, 10 (04): : S1 - S10
  • [9] Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality - The Multiple Risk Factor Intervention Trial experience
    Eberly, LE
    Cohen, JD
    Prineas, R
    Yang, LF
    [J]. DIABETES CARE, 2003, 26 (03) : 848 - 854
  • [10] Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
    Evans, JMM
    Wang, JX
    Morris, D
    [J]. BRITISH MEDICAL JOURNAL, 2002, 324 (7343): : 939 - 942A